INTRODUCTION
============

Vaccines against immunocastration can effectively suppress the reproductive function of farm animals \[[@b1-ajas-31-6-835],[@b2-ajas-31-6-835]\], wild animals \[[@b3-ajas-31-6-835],[@b4-ajas-31-6-835]\] and pets \[[@b5-ajas-31-6-835]\]. We aim to suppress temporarily reproductive function of wild and domestic animals during immunocastration and only restore reproductive ability only when necessary. Kisspeptins encoded by KISS1 metastasis suppressor (*KISS1*) gene are critical for the onset of puberty and the control of adult reproduction, which in turn controls secretion \[[@b6-ajas-31-6-835],[@b7-ajas-31-6-835]\]. Our previous study demonstrated that *KISS1* can be used as a novel target for developing a DNA immunocastration vaccine, wherein *KISS1* gene vaccine can effectively suppress the gonadal function by immune-mediated neutralizing activities \[[@b8-ajas-31-6-835]\]. The reversibility and safety of *KISS1* gene vaccine for immunocastration remains unclear.

The integration between this vaccine and host cell genomic DNA is an important security issue. Numerous studies showed that gene vaccines did not integrate into the genomic DNA of the host cell *in vivo* \[[@b9-ajas-31-6-835]--[@b11-ajas-31-6-835]\]; a few studies reported integration events *in vitro* \[[@b12-ajas-31-6-835],[@b13-ajas-31-6-835]\]. Given this gap in research, the integration between *KISS1* gene vaccine and the genomic DNA of the host cell should be evaluated to ensure its safety.

This study evaluates the reversibility of *KISS1* gene vaccine for immunocastration in ram lambs in terms of changes in anti-*KISS1* antibody titers, serum testosterone levels, scrotal circumference, testicle weight, and spermatogenesis in the seminiferous tubules. The safety of immunocastration against *KISS1* gene vaccine was evaluated in terms of the integration of fusion gene KS (*KISS1*- *HBsAg-S*, *HBsAg-S* refers to hepatitis B surface antigen S) of *KISS1* gene vaccine and genomic DNA of the host cell in vaccinated ram lambs.

MATERIALS AND METHODS
=====================

Animals
-------

Six healthy male Hu sheep (Hengtai Sheep Breeding Co., Ltd, Hubei, Huanggang, China) aged eight weeks were treated based on the National Institutes of Health Guides for the Care and Use of Laboratory Animals. These ram lambs were randomly allocated into group T and group C (3 lambs each) based on comparable scrotal circumference, body weight and date of birth ([Table 1](#t1-ajas-31-6-835){ref-type="table"}). Group T was the vaccinated group and group C was the control group.

Vaccination and sampling
------------------------

*KISS1* gene vaccine pKS-asd (asd refers to aspartate-β-semialdehyde dehydrogenase), an antibiotic-free recombinant plasmid encoding the human *KISS1* gene which fused with *HBsAg-S* gene, was successfully constructed in our laboratory \[[@b8-ajas-31-6-835]\]. Four milliliters of 0.25% lidocaine hydrochloride were intramuscularly injected in the quadriceps femoris of each ram lamb 24 h before immunization. Lambs in Group T were injected with 1 mg pKS-asd whereas lambs in group C were treated with 1 mg of pVAX-asd which is an empty vector without antibiotic resistance gene. All animals in both groups were boosted twice at an interval of three weeks. Blood samples were collected from the jugular vein before primary immunization (8 weeks of age) and at weeks 2, 4, 6, 10, 14, 22, and 30 after the primary immunization (10, 12, 14, 18, 22, 30, and 38 weeks of age). Serum was collected after centrifugation at 1,157×g at 4°C for 10 min and stored at −20°C for further use.

Detection of anti-*KISS1* antibodies
------------------------------------

Specific anti-kisspeptin-54 antibodies were detected by an indirect enzyme-linked immunosorbent assay (ELISA) method \[[@b8-ajas-31-6-835]\]. This process was followed by brief coating of 96-well ELISA plates with 100 ng/well of kisspeptin-54 diluted in a bicarbonate buffer (pH 9.6) overnight at 4°C. The samples were then washed with phosphate buffer saline with 0.05% Tween-20 (PBST) and blocking with 1% bovine serum albumin at 37°C for 1 h. Serum samples were serially 2-fold diluted in PBST from 1:25 up to 1:1,600, and then 100 μL were added to the wells and were incubated at 37°C for 1 h. Serum from a negative control from preimmune animals was also used. Bound antibodies were detected by adding horseradish peroxidase-labelled donkey anti-sheep IgG antibodies (Abbkine, Inc., Redlands, CA, USA) diluted 1/5,000 in PBST and incubated at 37°C for 1 h. Enzyme reaction was developed with tetramethylbenzidine substrate by incubating the plate at 37°C for 10 min. The reactions were stopped with 2 M H~2~SO~4~ and absorbance was determined at 450 nm in a plate reader (Bio-Rad iMark Microplate Absorbance Reader, Hercules, CA, USA). End-point titers were recorded as the reciprocal of the highest serum dilution, which yielded an absorbance greater than the mean plus two standard deviations of negative control samples at the same dilution \[[@b14-ajas-31-6-835],[@b15-ajas-31-6-835]\].

Detection of serum testosterone concentrations
----------------------------------------------

Serum testosterone concentrations (STCs) were detected by ELISA method using commercial kits and performed according to instructions of the manufacturer (Cusabio Biotech., Wuhan, China). The intra-assay coefficient of variation was less than or equal to 15% and the inter-assay coefficient of variation was less than or equal to 15%, respectively. Detection limit was 0.05 ng/mL.

*In situ* and *ex situ* of testicular size
------------------------------------------

After pushing the testicles to the bottom of the scrotum, the scrotal circumference of ram lambs was determined with a flexible plastic measuring tape \[[@b16-ajas-31-6-835]\]. The paired testes, including epididymis, were weighed after the ram lambs were slaughtered at 38 weeks of age. Testicular breadth and length were thereafter determined using Vernier's caliper.

Histological evaluation of reproductive organs
----------------------------------------------

The testes tissue samples of all animals were fixed with 10% (v/v) buffered neutral formalin and stained with Mayer's Haematoxylin and Eosin for histologic examination \[[@b17-ajas-31-6-835]\]. The diameter and circumference of seminiferous tubule for each animal was determined by measuring at least 15 tubules from multiple fields and averaging the values \[[@b18-ajas-31-6-835]\].

Detection of integration of plasmid DNA into host genomic DNA
-------------------------------------------------------------

These tissue samples, including hypothalamus, testis, heart, liver, lung, spleen, kidney, muscle and small intestine, were collected immediately after the ram lambs were slaughtered at 38 weeks of age and brought back to the laboratory at 4°C. These tissue samples with 0.25 to 0.5 g were separately selected and cut up, then genome DNA was extracted by a classical phenol-chloroform extraction method \[[@b19-ajas-31-6-835]\]. Detection of integration of plasmid DNA into host genomic DNA by polymerase chain reaction (PCR). PCR sensitivity was also distinguished by detecting known amounts of pKS-asd \[[@b16-ajas-31-6-835]\]. Plasmid concentration of pKS-asd was adjusted to 49 ng/μL which approximately contained 10^10^ copies/μL, The plasmid was then serially diluted 10-fold to 10^−1^, 10^−2^, 10^−3^, 10^−4^, 10^−5^, 10^−6^, 10^−7^, 10^−8^, 10^−9^, 10^−10^, which contained 10^9^, 10^8^, 10^7^, 10^6^, 10^5^, 10^4^, 10^3^, 10^2^, 10^1^, 10^0^ copies/μL, respectively. KS fusion gene (840 bp, sense of primers 5′-ATGGAGAACATCACATCAGGATT CCTAGGA-3′, anti-sense of primers 5′-GAAGCGCAGGCCG AAGGAGT-3′) from mixtures of 1 μL diluted plasmid and 1 μL (1 μg/μL) genomic DNA of control group lambs was amplified by PCR. KS fusion gene from genomic DNA 1 μL (1 μg/μL) of vaccinated ram lambs was amplified by PCR \[[@b9-ajas-31-6-835],[@b16-ajas-31-6-835]\]. The PCR reaction was consisted of 25 μL mix liquids containing 1 μL of template DNA (1 μg), 0.5 μL of *Taq* polymerase (5 U/μL), 2 μL dNTPs (2.5 mmol/L), 1.0 mL of each primer (75 ng/μL), 17 μL of ddH~2~O, and 2.5 μL 10×reaction buffer (with 20 mM MgCl~2~). The PCR programmed conditions included an initial incubation at 95°C for 5 mins followed by 3-step cycling conditions for 35 cycles; 95°C denaturation for 30 s, 55°C annealing for 30 s, 72°C elongation for 20 s, and a final cycle for 10 mins at 72°C. The PCR products were detected by electrophoresis with 1.2% polyacrylamide gel.

Statistical analysis
--------------------

The differences between groups in terms of anti-*KISS1* antibody titers, scrotal circumference, serum testosterone concentration, testis weight, testicular breadth, testicular length, tubule diameter, and circumference were analyzed by unpaired student's *t*-test of SAS 8.1 (SAS Institute, Inc., Cary, NC, USA). Less than 0.05 p value was considered statistically significant and data were expressed as mean±standard deviation.

RESULTS
=======

Anti-*KISS1* antibody response, serum testosterone level and scrotal circumference
----------------------------------------------------------------------------------

*KISS1*-specific antibody titers in vaccinated lambs (Group T) were significantly higher than that in control animals from week 4 to 14 after primary immunization ([Figure 1A](#f1-ajas-31-6-835){ref-type="fig"}, p\<0.05). However, no significant difference was observed in anti-*KISS1* antibody titers between the two groups at weeks 22 and 30 after the primary immunization.

STC in vaccinated lambs (Group T) were significantly lower than in control lambs (Group C) from week 4 to 14 after primary immunization ([Figure 1B](#f1-ajas-31-6-835){ref-type="fig"}, p\<0.05). However, no significant difference was observed in testosterone concentrations between the two groups at weeks 22 and 30 after the primary immunization.

Scrotal circumference in vaccinated animals was significantly lower than in control animals at weeks 6, 10, 14, and 22 after the primary immunization ([Figure 1C](#f1-ajas-31-6-835){ref-type="fig"}, p\<0.05). No significant difference was observed in scrotal circumference between the two groups at week 30 after primary immunization.

Weight of testes and microscopic evaluation
-------------------------------------------

No significant difference was observed in testicle weight, length and breadth between vaccinated and control group animals ([Table 2](#t2-ajas-31-6-835){ref-type="table"}; [Figure 2Aa, Ab](#f2-ajas-31-6-835){ref-type="fig"}) at week 30 after primary immunization.

The results of the microscopic examination showed no clear difference between the densities of spermatogonia type A, primary spermatocytes at the pachytene stage, spermatids at the zygotene stage and spermatozoa in the seminiferous tubules of vaccinated ([Figure 2Ba](#f2-ajas-31-6-835){ref-type="fig"}) and control lambs ([Figure 2Bb](#f2-ajas-31-6-835){ref-type="fig"}) at week 30 after the primary immunization. The normal process of spermatogenesis was evident in the seminiferous tubules of lambs in both groups ([Figure 2B](#f2-ajas-31-6-835){ref-type="fig"}). No significant difference was observed in seminiferous tubule diameter and circumference between vaccinated and control group animals ([Table 2](#t2-ajas-31-6-835){ref-type="table"}) at week 30 after the primary immunization.

Detection of integration of plasmid DNA into host genomic DNA
-------------------------------------------------------------

The sensitivity of PCR was approximately 10 copies of plasmid in 1 μg genomic DNA ([Figure 3A](#f3-ajas-31-6-835){ref-type="fig"}). No KS fusion fragments at this sensitivity level were noted in genomic DNA in the samples of nine different tissues obtained from vaccinated ram lambs ([Figure 3B](#f3-ajas-31-6-835){ref-type="fig"}).

DISCUSSION
==========

Immunocastration is an effective method for suppressing the reproduction of different animal species \[[@b20-ajas-31-6-835]--[@b22-ajas-31-6-835]\]. Gene vaccine is a superior method of immunocastration because of its lower costs than other synthetic peptide or protein vaccines. However, previous studies that used immunocastration gene vaccine are mainly focused on the effects of immunocastration \[[@b8-ajas-31-6-835],[@b17-ajas-31-6-835],[@b23-ajas-31-6-835]\] with little information on the reversibility and safety of immunocastration gene vaccines.

The present study found that *KISS1* gene immunocastration was reversible in ram lambs. Anti-*KISS1* antibody response in the vaccinated group was detected in previous and current studies from week 4 to 14 after the primary immunization \[[@b8-ajas-31-6-835]\]. However, the anti-*KISS1* antibody response in this study rapidly decreased at weeks 22 and 30 after the primary immunization. This finding resulted in a lack of significant difference in anti-*KISS1* titers between the vaccinated and the control ram lambs. The rapid decrease of anti-*KISS1* antibody response could be attributed to the shift of immune type from the predominant Th2 type (humoral immune response) to a Th1 type (cellular immune response) or a balance of Th1/Th2 type release \[[@b24-ajas-31-6-835]--[@b27-ajas-31-6-835]\]. A substantial amount of plasmid pKS-asd and antigens of endogenous synthesis can be cleared by macrophages because of increased cellular immune response. The immunization of ram lambs with *KISS1* gene vaccine suppressed production of serum testosterone at weeks 4, 6, 10, and 14 after primary immunization. This finding could have resulted in the suppression of scrotal circumference growth at week 6, 10, 14, and 22 after the primary immunization. Previous study also showed that the immunization of subject ram lambs with *KISS1* gene vaccine suppressed the production of serum testosterone and scrotal circumference growth from week 4 to 14 and week 6 to 14 after the primary immunization, respectively \[[@b8-ajas-31-6-835]\]. However, slight suppression of production of serum testosterone in vaccinated group lambs was observed in the current study at weeks 22 and 30 after primary immunization. This finding could have resulted in slight suppression of scrotal circumference growth, testicular weight, length, breadth and spermatogenesis in seminiferous tubules at week 30 after the primary immunization. The testosterone level and scrotal circumference in control animals continued to increase until 14 weeks after the primary immunization and sharply dropped or slowly increased afterwards. This finding could be attributed to the age of animals, namely, the occurrence of puberty at 22 weeks of age. Our results showed that a *KISS1*-antagonistic gene vaccine could produce high anti-*KISS1* antibody response and suppress the production of serum testosterone thereby resulting in the suppression of growth and development of testis. However, the inhibition of *KISS1*-antagonistic gene vaccine on the growth and development of testis gradually disappeared with the decline of anti-*KISS1* antibody titers and recovery of serum testosterone. The gray vertical area in [Figure 1](#f1-ajas-31-6-835){ref-type="fig"} shows that the inflexion of testis growth recovery could occur between week 14 and 22 after the primary immunization. This finding is a result of the sharp increase in serum testosterone and scrotal circumference in the vaccinated group, which could have resulted in the compensation of serum testosterone secretion and testis growth. Previous studies showed that several anti-GnRH-vaccines can decrease testosterone concentrations and testicular dimension in male animals, and serum progesterone concentrations and cyclic ovarian activity in female animals. However, the effects of the anti-GnRH-vaccines are reversible \[[@b28-ajas-31-6-835]--[@b30-ajas-31-6-835]\]. The current study showed that the effects of *KISS1* gene immunocastration were also reversible in ram lambs.

We did not detect KS fusion fragment of *KISS1* gene vaccine integrated in the genomic DNA of the host cell in nine different tissues in vaccinated ram lambs. This finding indicated that *KISS1* gene vaccine did not integrate into the host cell genomic DNA of vaccinated ram lambs. The potential frequency of integration of plasmid pKS-asd into host genomic DNA was lower than the spontaneous number of mutations. This finding indicated that pKS-asd is genetically safe for use as immunocastration gene vaccine. Previous studies also showed that the gene vaccines did not integrate *in vivo* into the genomic DNA of host cells \[[@b16-ajas-31-6-835],[@b31-ajas-31-6-835]\]. Therefore, these results demonstrate a lack of integration events for *KISS1* gene immunocastration.

In conclusion, *KISS1* gene immunocastration was reversible without integration to the host genome. Further studies should be conducted to investigate the effect of *KISS1* gene vaccine in controlling fertility by the mating trials in rams and other pets. Other safety aspects such as long-term persistence and vertical transmission should also be further studied.

**CONFLICT OF INTEREST**

We certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

This work was financially supported the Fundamental Research Funds for the Central Universities (No. XDJK2016C018, No. SWU115066), the National Natural Science Foundation of China (No. 31772598), the China National Meat-type Sheep and Goat Industrial Technology System (No. CARS-38), Chongqing Research Program of Basic Research and Frontier Technology (No. cstc2015jcyjBX0002).

![(A) Anti-*KISS1* antibodies titers, (B) serum testosterone concentrations, and (C) scrotal circumference in ram lambs immunized with pKS-asd (Group T) and pVAX-asd (Group C) at weeks 0, 2, 4, 6, 10, 14, 22, and 30 after the primary immunization. Vaccinations were respectively conducted at weeks 0, 3, and 6 weeks after primary immunization (8, 11, and 14 weeks of age). Data are presented as means±standard deviation. \* p\<0.05.](ajas-31-6-835f1){#f1-ajas-31-6-835}

![(A) Appearance and (B) microscopic evaluation of testis of ram lambs from (Aa, Ba) treated and (Ab, Bb) control groups at week 30 after the primary immunization (38 weeks of age). Photomicrographs of the cross-sections of seminiferous tubules represent the stages of spermatogenesis of seminiferous epithelium: spermatogonia type A (short arrows), primary spermatocytes at the pachytene stage (long arrows), spermatids at the zygotene stage (ellipse area) and spermatozoa (rectangular area). H&E, scale bar −50 μm or 100 μm (insets).](ajas-31-6-835f2){#f2-ajas-31-6-835}

![Detection of polymerase chain reaction (PCR) sensitivity and integration of plasmid pKS-asd into the host genomic DNA. Sensitivity of PCR detection for pKS-asd positive plasmid DNA in the host genomic DNA (A), lane 1--10: 10^−1^, 10^−2^, 10^−3^, 10^−4^, 10^−5^, 10^−6^, 10^−7^, 10^−8^, 10^−9^, 10^−10^ dilution of pKS-asd plasmid, respectively, lane M: 100 bp ladder DNA Marker (3,000 bp); Results of plasmid pKS-asd integration into the host genomic DNA (B), lane 1: amplification of pKS-asd (positive control) for *KS* (*KISS1* metastasis suppressor and hepatitis B surface antigen *S*) gene (840 bp), lanes 2--10: amplification of genome DNA from hypothalamus, testis, heart, liver, lung, spleen, kidney, muscle, and small intestine, respectively, of vaccinated ram lambs for *KS* gene; lane M: 100 bp ladder DNA Marker (3,000 bp).](ajas-31-6-835f3){#f3-ajas-31-6-835}

###### 

Scrotal circumference, body weight and date of birth in vaccinated (Group T) and control (Group C) ram lambs when ram lambs of 8-week-old were randomly grouped

  Group   Traits                    
  ------- ------------ ------------ ------------
  T       11.27±0.68   15.12±0.55   11/13/2013
  C       11.34±0.76   15.05±0.58   11/13/2013

There was no significant difference between vaccinated (Group T) and control (Group C) for all traits in this table.

###### 

Testicle weight, length, breadth, seminiferous tubule diameter and circumference in vaccinated (Group T) and control (Group C) ram lambs at week 30 after primary immunization (age for 38 weeks)

  Group   Traits                                                
  ------- -------------- ----------- ----------- -------------- --------------
  T       190.97±28.09   6.52±0.12   4.74±0.15   205.05±14.21   672.82±41.36
  C       207.70±28.23   6.69±0.21   4.78±0.54   206.89±15.62   677.07±44.05

There was no significant difference between vaccinated (Group T) and control (Group C) for all traits in this table.
